Is barakol anxiolytic?

Behavioural Pharmacology

Volumn 9, Issue 4, 1998, Pages 375-378

  Fiorino, D F ^a   Treit, D ^b   Menard, J ^b   Lermer, L ^a   Phillips, A G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anxiolytic; Barakol; Elevated plus maze; Rat; Shock probe burying

Indexed keywords

ANXIOLYTIC AGENT; PLANT EXTRACT;

ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; RAT; SENNA;

CASSIA SIAMEA;

EID: 0031871810     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199807000-00010     Document Type: Article

References (9)

1. Bycroft BW, Hassaniali-Waiji A, Johnson AW, King TJ (1970). The structure and synthesis of barakol: a novel dioxaphenalene derivative from Cassia siamea. J Chem Soc 12:1686-1689.
2. Menard J, Treit D (1998). The septum and the hippocampus differentially mediate the anxiolytic effects of R(+)-8-OH-DPAT. Behav Pharmacol 9:1-9.
3. Menard J, Treit D (1996). Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests. Physiol Behav 60:845-853.
4. Pellow S, Chopin P, File SE, Briley M (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167.
5. Pesold C, Treit D (1994). The septum and the amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 638:295-301.
6. Rodgers RJ, Johnson NJT (1995). Factor analysis of spatiotemporal and ethological measures in the murine-elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52:297-303.
7. Thongsaard W, Deachapunya C, Pongsakorn S, Boyd EA, Bennett GW, Marsden CA (1996). Barakol: a potential anxiolytic extracted from Cassia siamea. Pharmacol Biochem Behav 53:753-759.
8. Treit D (1990). A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burying test for anxiolytics. Pharmacol Biochem Behav 36:203-205.
9. Treit D, Pesold C, Rotzinger S (1993). Dissociating the antifear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behav Neurosci 107:770-785.